Final Ruling in Controversial Glucose Case

In a significant legal development, the Cologne Regional Court's verdict against a pharmacist has been upheld, affirming her two-year probation sentence for a grave error that resulted in tragic fatalities. The case centers around an incident in 2019 when the pharmacist mistakenly mixed a residue of lidocaine with glucose, subsequently creating a contaminated solution used in a routine diabetes test for pregnant women.

This error had devastating consequences, leading to the death of a young mother and her unborn child, who was delivered via emergency cesarean section. The court found the pharmacist guilty of negligent homicide and failure to provide assistance. Initially charged with attempted murder due to her inaction, the court determined that this was not substantiated.

Following the initial ruling in the fall of 2023, the pharmacist sought to appeal the decision at the Federal Court of Justice (BGH). However, the BGH's Second Criminal Senate has now concluded the proceedings, specifically concerning the charge of failure to assist, citing economic reasons for this cessation.

The BGH's communication indicated that a further review of the case did not reveal any legal errors that would implicate the defendant. Consequently, her conviction for negligent homicide, combined with negligent bodily harm, resulting in a sentence of one year and ten months, has been rendered final. Notably, two months of the imposed sentence have already been served, according to the judicial process.

This case has raised broader discussions regarding pharmaceutical practices and the stringent adherence to protocols to safeguard patient health. The implications of the ruling are being closely monitored within the healthcare community, emphasizing the importance of diligence in pharmaceutical preparations.